Literature DB >> 18622506

[Assessment of the quality of life of patients with lung cancer using the Medical Outcomes Study 36-item Short-Form Health Survey].

Juliana Franceschini1, Alecssandra Aparecida Dos Santos, Inás El Mouallem, Sergio Jamnik, César Uehara, Ana Luisa Godoy Fernandes, Ilka Lopes Santoro.   

Abstract

OBJECTIVE: To assess the quality of life of patients with lung cancer and to compare it with that of individuals without cancer.
METHODS: The Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) was administered to 57 patients diagnosed with lung cancer, treated at the Lung Cancer Outpatient Clinic of the Hospital São Paulo, and to a control group of 57 individuals recruited from the Extra Penha workout group. The Mann-Whitney test was used to compare the groups, domain by domain. The first model of logistic regression was adjusted for male gender, nonsurgical treatment, Karnofsky performance status and smoking, which were included as predictors. The second model was adjusted for each SF-36 domain in order to identify increases in the proportions of patients in stage IIIB or IV.
RESULTS: The lung cancer group and the control group presented the following mean scores, respectively, for the SF-36 domains: role limitations due to physical health problems, 29.39 +/- 36.94 and 82.89 +/- 28.80; role limitations due to emotional problems, 42.78 +/- 44.78 and 86.55 +/- 28.77; physical function, 56.49 +/- 28.39 and 89.00 +/- 13.80; vitality, 61.61 +/- 23.82 and 79.12 +/- 17.68; bodily pain, 62.72 +/- 28.72 and 81.54 +/- 19.07; general health, 62.51 +/- 25.57 and 84.47 +/- 13.47; emotional well-being, 68.28 +/- 23.46 and 82.63 +/- 17.44; and social functioning, 72.87 +/- 29.20 and 91.67 +/- 17.44. The logistic regression model showed that role limitations due to physical health problems, physical function and emotional well-being were predictors of stages IIIB and IV.
CONCLUSIONS: The patients with lung cancer had a poorer quality of life, especially regarding physical aspects, than did the control subjects.

Entities:  

Mesh:

Year:  2008        PMID: 18622506     DOI: 10.1590/s1806-37132008000600009

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  6 in total

1.  Quality of life and physical limitations in primary brain tumor patients.

Authors:  Mariana R Gazzotti; Suzana M F Malheiros; Marcela Batan Alith; Oliver Nascimento; Ilka Lopes Santoro; José R Jardim; Milena Vidotto
Journal:  Qual Life Res       Date:  2011-04-22       Impact factor: 4.147

2.  Comorbidities, treatment-related consequences, and health-related quality of life among rural cancer survivors.

Authors:  Shaila M Strayhorn; Leslie R Carnahan; Kristine Zimmermann; Theresa A Hastert; Karriem S Watson; Carol Estwing Ferrans; Yamilé Molina
Journal:  Support Care Cancer       Date:  2019-07-24       Impact factor: 3.603

3.  Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy-Lung (FACT-L) and the FACT-Lung Symptom Index (FLSI).

Authors:  Franceschini Juliana; José R Jardim; Ana Luisa Godoy Fernandes; Sérgio Jamnik; Ilka Lopes Santoro
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

4.  Family caregiver burden: the burden of caring for lung cancer patients according to the cancer stage and patient quality of life.

Authors:  Eliana Lourenço Borges; Juliana Franceschini; Luiza Helena Degani Costa; Ana Luisa Godoy Fernandes; Sérgio Jamnik; Ilka Lopes Santoro
Journal:  J Bras Pneumol       Date:  2017-01-23       Impact factor: 2.624

5.  Relationship between the magnitude of symptoms and the quality of life: a cluster analysis of lung cancer patients in Brazil.

Authors:  Juliana Franceschini; José Roberto Jardim; Ana Luisa Godoy Fernandes; Sérgio Jamnik; Ilka Lopes Santoro
Journal:  J Bras Pneumol       Date:  2013 Jan-Feb       Impact factor: 2.624

6.  Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients' survival.

Authors:  Irawati Lemonnier; Francis Guillemin; Patrick Arveux; Christelle Clément-Duchêne; Michel Velten; Marie-Christine Woronoff-Lemsi; Damien Jolly; Cédric Baumann
Journal:  Health Qual Life Outcomes       Date:  2014-05-15       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.